Cáncer de mama y cáncer de mama metastásico
1. El cáncer de mama en España - GEICAM - Investigación en Cáncer de Mama.
Accessed March 12, 2024. https://www.geicam.org/sala-de-prensa/el-cancer-de-mama-en-espana
2. Cáncer de mama | Memorial Sloan Kettering Cancer Center. Accessed March 12,
2024. https://www.mskcc.org/es/cancer-care/types/breast#header-0
3. Martín M, Carrasco E, Álvaro Rodríguez-Lescure ·, et al. Long-term outcomes
of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies
and El Álamo IV registry. Breast Cancer Res Treat. 2023;201:151-159. doi:10.1007/s10549-023-07002-1
4. Salvo EM, Oliva Ramirez A, Cueto J, et al. Risk of recurrence among
patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy:
A systematic review and meta-analysis. The Breast. 2021;57:5-17. doi:10.1016/j.breast.2021.02.009
5. Pan H, Gray R, Braybrooke J, et al. 20-Year Risks of Breast-Cancer
Recurrence after Stopping Endocrine Therapy at 5 Years. N Engl J Med. 2017;377(19):1836-1846.
doi:10.1056/NEJMOA1701830/SUPPL_FILE/NEJMOA1701830_DISCLOSURES.PDF
6. Asociación Española Contra el Cáncer (AECC): Cáncer de mama
7. Sociedad Española de Oncología Médica (SEOM): Cáncer de mama
8. Las cifras del cáncer de SEOM 2024
9. Medline Plus: Terapia de reemplazo hormonal
10. Medline Plus: Cáncer de mama
11. American Cancer Society: Cáncer de seno
12. Cancer.net (ASCO): Breast Cancer Guide
13. Guía ESMO para pacientes de cáncer de mama
14. Centers for Disease Control and Prevention (CDC): Información básica sobre
el cáncer de mama
15. Mirza, A. N., Mirza, N. Q., Vlastos, G., & Singletary, S. E. (2002).
Prognostic factors in node-negative breast cancer: a review of studies with sample size more than
200 and follow-up more than 5 years. Annals of surgery, 235(1), 10–26.
https://doi.org/10.1097/00000658-200201000-00003
16. Rowlings, P. A., Williams, S. F., Antman, K. H., Fields, K. K., Fay, J.
W., Reed, E., Pelz, C. J., Klein, J. P., Sobocinski, K. A., Kennedy, M. J., Freytes, C. O.,
McCarthy, P. L., Jr, Herzig, R. H., Stadtmauer, E. A., Lazarus, H. M., Pecora, A. L., Bitran, J. D.,
Wolff, S. N., Gale, R. P., Armitage, J. O., … Horowitz, M. M. (1999). Factors correlated with
progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
for metastatic breast cancer. JAMA, 282(14), 1335–1343. https://doi.org/10.1001/jama.282.14.1335
17. Chung, M., Chang, H. R., Bland, K. I., & Wanebo, H. J. (1996). Younger
women with breast carcinoma have a poorer prognosis than older women. Cancer, 77(1), 97–103.
https://doi.org/10.1002/(SICI)1097-0142(19960101)77:1<97::AID-CNCR16>3.0.CO;2-3
18. Kamby, C., Vejborg, I., Kristensen, B., Olsen, L. O., & Mouridsen, H. T.
(1988). Metastatic pattern in recurrent breast cancer. Special reference to intrathoracic
recurrences. Cancer, 62(10), 2226–2233.
https://doi.org/10.1002/1097-0142(19881115)62:10<2226::aid-cncr2820621026>3.0.co;2-dDirectrices de
práctica clínica en oncología de la NCCN (NCCN Guidelines®) para el cáncer de mama V.3.2023. ©
National Comprehensive Cancer Network, Inc. 2023. Reservados todos los derechos
19. Loibl, S., Varga, A., Bachelot, T., Barrios, C. H., Bergh, J., Burstein,
H. J., Cardoso, L., Carey, L. A., Dawood, S., Del Mastro, L., Denkert, C., Fallenberg, E. M.,
Francis, P. A., Gamal‐El‐Din, H., Gelmon, K. A., Geyer, C. E., Gnant, M., Guarneri, V., Gupta, S., …
Harbeck, N. (2023b). Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment
and follow-up. Annals Of Oncology. https://doi.org/10.1016/j.annonc.2023.11.016
20. De la Peña, F. A., Novoa, S. A., Gregori, J. G., Cortijo, L. G., Carrasco,
F. H., Martínez, M. T., Estévez, C. M., Stradella, A., Vidal, M., & Ciruelos, E. (2023).
SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022). Clinical & Translational
Oncology, 25(9), 2647-2664. https://doi.org/10.1007/s12094-023-03215-4
21. Gennari, A., André, F., Barrios, C. H., Cortés, J., De Azambuja, E.,
DeMichele, A., Dent, R., Fenlon, D., Gligorov, J., Hurvitz, S. A., Im, S., Krug, D., Kunz, W. G.,
Loi, S., Penault-Llorca, F., Ricke, J., Robson, M. E., Rugo, H. S., Saura, C., … Harbeck, N. (2021).
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with
metastatic breast cancer. Annals Of Oncology, 32(12), 1475-1495.
https://doi.org/10.1016/j.annonc.2021.09.019. ESMO Metastatic Breast Cancer Living Guidelines, v1.1
May 2023.
22. Garcia-Saenz, J. A., Blancas, I., Echavarria, I., Hinojo, C., Margeli, M.,
Moreno, F., Pernas, S., Ramon Y Cajal, T., Ribelles, N., & Bellet, M. (2023). SEOM-GEICAM-SOLTI
clinical guidelines in advanced breast cancer (2022). Clinical & translational oncology: official
publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of
Mexico, 25(9), 2665–2678. https://doi.org/10.1007/s12094-023-03203-8
